Kiniksa Pharmaceuticals
KNSA
#4662
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
P/S ratio for Kiniksa Pharmaceuticals (KNSA)
P/S ratio as of May 2024 (TTM): 5.27
According to Kiniksa Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.27079. At the end of 2023 the company had a P/S ratio of 4.57.
P/S ratio history for Kiniksa Pharmaceuticals from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.57 | -3.5% |
| 2022 | 4.73 | -77.51% |
| 2021 | 21.0 | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |